Several reports demonstrated that RELL2 exhibits antitumor activity; for example, RELL2 reduces breast cancer cell invasion and migration and inhibits the tumorigenesis of esophageal cancer cells [3, 4]. This evidence concerns the gene RELL2 and breast carcinoma.